CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Phanstiel S. Louise Director | Grant or award | +59,701 | 341,652 | ||
| 2026-06-04 | Dreismann Heinrich Director | Grant or award | +59,701 | 231,145 | ||
| 2026-06-04 | Bisaro Paul Director | Grant or award | +59,701 | 157,142 | ||
| 2026-06-01 | Jampa Raj Chief Technology Officer | Grant or award | +251,889 | 251,889 | ||
| 2026-05-14 | Bisaro Paul Director | Purchase | +7,500 | $3.69 | $28K | 97,441 |
| 2026-05-01 | Donnelly Brian J Chief Commerical Officer | Shares withheld for taxes | −55,975 | $4.80 | $269K | 568,363 |
| 2026-04-14 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −946 | $4.91 | $5K | 326,310 |
| 2026-04-14 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −1,069 | $4.91 | $5K | 629,646 |
| 2026-03-22 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −549 | $4.58 | $3K | 298,509 |
| 2026-03-22 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −2,019 | $4.58 | $9K | 327,256 |
| 2026-03-22 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −2,055 | $4.58 | $9K | 630,715 |
| 2026-03-15 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −877 | $4.66 | $4K | 301,250 |
| 2026-03-15 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −2,192 | $4.66 | $10K | 299,058 |
| 2026-03-15 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −4,783 | $4.66 | $22K | 341,224 |
| 2026-03-15 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −11,949 | $4.66 | $56K | 329,275 |
| 2026-03-15 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −3,355 | $4.66 | $16K | 188,404 |
| 2026-03-15 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −8,382 | $4.66 | $39K | 180,022 |
| 2026-03-15 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −5,611 | $4.66 | $26K | 641,866 |
| 2026-03-15 | Verratti Mark Chief Operating Officer | Shares withheld for taxes | −9,096 | $4.66 | $42K | 632,770 |
| 2026-03-14 | Wheeler Benjamin Richard Chief Financial Officer | Shares withheld for taxes | −1,097 | $4.66 | $5K | 302,127 |
Page 2 of 15 · 286 trades